Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Beat The Street With SI Traders -- Ignore unavailable to you. Want to Upgrade?

To: 3bar who wrote (214069)	9/21/2021 6:05:47 PM
From: stuffbug	Read Replies (1) \| Respond to of 233807

acetominophen, not aspirin I don't believe Dr. Malone is associated with a clinic, but he is affiliated with an early treatment medicine undergoing clinical trials and is certainly speaking out and asking all the appropriate questions. Barrons has recently run articles on the race to develop antivirals (protease inhibitors) to combat covid-19. Ivermectin is a well known protease inhibitor but is unfortunately (for Big Pharma) off patent. barrons.com 2006 NIH paper. I suspect the 2020 numbers are higher by 20% or so. Results: Analysis of national databases show that acetaminophen-associated overdoses account for about 56,000 emergency room visits and 26,000 hospitalizations yearly. Analysis of national mortality files shows 458 deaths occur each year from acetaminophen-associated overdoses; 100 of these are unintentional. pubmed.ncbi.nlm.nih.gov